Vivobio Labs Private Limited, a active private limited company, was established on 23 October 2009 in Hyderabad, Telangana, India. Engaging in consumer professional services within the travel and hospitality sector, it holds CIN: U73100TG2009PTC065603. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shyam Sunder Tipparaju (Director), Kalyan Ram Mangipudi (Director), Sankaranarayanan Alangudi (Director). Past directors included Sri Kalyan Kompella, Tejomurthula Viswaswara Kaladhar Kuppambhotla, Shyam Sunder Tipparaju. It holds ₹55.51 Cr open charges and ₹6.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 8-2-672/5&6, 3Rd Floor, Ilyas Mohammed Khan Estate Road No.1, Banjara Hills, Hyderabad, Telangana, 500034.
U73100TG2009PTC065603
065603
23 October 2009
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vivobio Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Sunder Tipparaju | Director | 05 Feb 2024 | Current |
| Kalyan Ram Mangipudi | Director | 09 Feb 2018 | Current |
| Sankaranarayanan Alangudi | Director | 23 Oct 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 12 Oct 2010 | Past |
| Pramod Abcsdd | Director | 01 Apr 2023 | Past |
| Pramod Abcsdd | Director | 01 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vivobio Labs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Vivobio Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹555,074,437.00
₹60,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2016 | Canara Bank | ₹55.51 Cr | Open |
| 17 Jul 2013 | Bank Of Baroda | ₹3.00 Cr | Satisfied |
| 11 Jul 2013 | Bank Of Baroda | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vivobio Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vivobio Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivobio Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vivobio Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Vivobio Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Shyam Sunder Tipparaju was appointed as a Director was appointed as a Director on 05 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
A charge with Canara Bank of Rs. 555.07 M registered on 14 Oct 2016 with Charge ID 100075759 was modified on 25 Feb 2022. was recorded as a recent event.
Progress on A charge registered on 17 Jul 2013 via Charge ID 10447970 with Bank Of Baroda was fully satisfied on 26 Mar 2019. was documented.
A charge registered on 11 Jul 2013 via Charge ID 10436961 with Bank Of Baroda was fully satisfied on 26 Mar 2019. was recorded as a recent event.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe's first in vivo genome editing study..
The CIN of Vivobio Labs Private Limited is U73100TG2009PTC065603.
Vivobio Labs Private Limited is headquartered at 8-2-672/5&6, 3Rd Floor, Ilyas Mohammed Khan Estate Road No.1, Banjara Hills, Hyderabad, Telangana, 500034.
Vivobio Labs Private Limited was incorporated on 23 October 2009.
The current directors of Vivobio Labs Private Limited are
The primary industry of Vivobio Labs Private Limited is Travel And Hospitality.
Vivobio Labs Private Limited is unlisted.
The authorized capital of Vivobio Labs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Vivobio Labs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX